An SopB-mediated immune escape mechanism of Salmonella enterica can be subverted to optimize the performance of live attenuated vaccine carrier strains.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Link, ClaudiaEbensen, Thomas
Ständner, Lothar
Déjosez, Marion
Reinhard, Elena
Rharbaoui, Faiza
Guzmán, Carlos A
Issue Date
2006-07
Metadata
Show full item recordAbstract
Salmonellae have evolved several mechanisms to evade host clearance. Here, we describe the influence on bacterial immune escape of the effector protein SopB, which is translocated into the cytosol through a type III secretion system. Wild-type bacteria, as well as the sseC and aroA attenuated mutants exerted a stronger cytotoxic effect on dendritic cells (DC) than their SopB-deficient derivatives. Cells infected with the double sseC sopB, phoP sopB and aroA sopB mutants also exhibited higher expression of MHC, CD80, CD86 and CD54 molecules, and showed a stronger capacity to process and present an I-E(d)-restricted epitope from the influenza hemagglutinin (HA) to CD4+ cells from TCR-HA transgenic mice in vitro. The incorporation of an additional mutation into the sopB locus of the attenuated sseC, phoP and aroA mutants resulted in the stimulation of improved humoral and cellular immune responses following oral vaccination. The obtained results define a new potential immune escape strategy of this important pathogen, and also demonstrate that this mechanism can be subverted to optimize the immune responses elicited using Salmonella as a live vaccine carrier.Citation
An SopB-mediated immune escape mechanism of Salmonella enterica can be subverted to optimize the performance of live attenuated vaccine carrier strains. 2006, 8 (8):2262-9 Microbes Infect.Affiliation
Department of Vaccinology, Division of Microbiology, GBF-German Research Centre for Biotechnology, Mascheroder Weg 1, D-38124 Braunschweig, Germany.PubMed ID
16793312Type
ArticleLanguage
enISSN
1286-4579ae974a485f413a2113503eed53cd6c53
10.1016/j.micinf.2006.04.013
Scopus Count
Related articles
- SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
- Authors: Nagarajan AG, Balasundaram SV, Janice J, Karnam G, Eswarappa SM, Chakravortty D
- Issue date: 2009 May 11
- Salmonella infection of afferent lymph dendritic cells.
- Authors: Chan SS, Mastroeni P, McConnell I, Blacklaws BA
- Issue date: 2008 Feb
- A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.
- Authors: Li Y, Wang S, Xin W, Scarpellini G, Shi Z, Gunn B, Roland KL, Curtiss R 3rd
- Issue date: 2008 Nov
- Virulence attenuation and live vaccine potential of aroA, crp cdt cya, and plasmid-cured mutants of Salmonella enterica serovar Abortusovis in mice and sheep.
- Authors: Uzzau S, Marogna G, Leori GS, Curtiss R 3rd, Schianchi G, Stocker BA, Rubino S
- Issue date: 2005 Jul
- [Characterization of attenuated Salmonella C500 strain with a delta asd mutant and use as an Asd+ balanced-lethal host-vector system].
- Authors: Zhao Z, Xu Y, Wu B, Cheng X, Li Y, Tang X, Zhang C, Chen H
- Issue date: 2009 Jan